Global Proteomics Market, By Application (Clinical Diagnostic, Drug Discovery, Diagnostic Biomarker Discovery, Others), By Indication (Oncology, Infectious Disease, Respiratory, Cardiology, Others), By Technology (Conventional, Advanced, Quantitative, High-throughput, Bioinformatic Analysis), By Type (Expression, Functional, Structural, Computational), By Product (Reagents and Assays, Instruments, Software & Services), By End-User (Pharmaceutical and Biotechnology Companies, Research Institutes, CROs), By Region, Competition, Forecast & Opportunities, 2026F
Global proteomics market is expected to undergo a healthy growth during the forecast period and is projected to reach USD66.59 billion by 2026. The key factor responsible for increased demand for proteomics is the growing investments in research and development activities in end use industries such as biotechnology sector and pharmaceutical industry. Additionally, increasing demand for personalized medicine is anticipated to bode well for the growth of proteomics market across the globe in the coming years. Moreover, increasing government support in terms of providing funds is anticipated to bolster the market growth through 2026. However, the market is constrained by strict regulatory norms and the high cost of the instruments.
The global proteomics market is segmented based on application, indication, technology, type, product, end-user, region and company. Based on application, the market can be segmented into clinical diagnostic, drug discovery, diagnostic biomarker discovery, others. Out of which, the clinical diagnostics segment dominated the market in terms of largest market size in 2020 and is further anticipated to maintain its leading position during the forecast period as well. This growth can be accredited to enhanced knowledge of understanding the patterns of protein expression for disease diagnostics and development of drug. Also, tandem mass spectrometry and liquid chromatography are some proteomics technologies that are effective for the identification of proteins, thus boosting the growth of the segment across the globe. Based on indication, the market is segmented into oncology, infectious disease, respiratory, cardiology, others. Out of which, infectious disease segment is expected to undergo the fastest CAGR during the forecast period due to the increasing incidence of infectious diseases.
Major players operating in the global proteomics market include Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Waters Corporation, Bio-Rad Laboratories, Inc., Danaher Corporation (SCIEX), GE Healthcare, Inc., PerkinElmer, Inc., Becton, Dickinson and Company, Illumina, Inc., Biocon Limited, Qiagen N.V., Bruker Corporation, Luminex Corporation, Evotec SE, Horiba, Ltd., Creative Proteomics, Promega Corporation, CellCarta Precision Medicine, Inc., Bioproximity LLC, Applied Biomics, Inc., etc. The companies operating in proteomics market across the globe are focusing more towards expanding their share in the market. Rising competitiveness is anticipated to drive innovation in the market, therefore helping the industry to solve existing challenges and meet the unmet needs in the market. Furthermore, the market players are focusing on R&D activities to enhance their product portfolios. Also, they are adopting strategies such as collaborations and acquisitions to further bolster their status in the proteomics market. For instance, many companies working with mass spectrometry and both the manufacturers and end-user labs are collaborating with protein chip-related companies.
Years considered for this report:
TechSci Research calculated the market size of global proteomics market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.
Key Target Audience:
Report Scope:
In this report, global proteomics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in global proteomics market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
The global proteomics market is segmented based on application, indication, technology, type, product, end-user, region and company. Based on application, the market can be segmented into clinical diagnostic, drug discovery, diagnostic biomarker discovery, others. Out of which, the clinical diagnostics segment dominated the market in terms of largest market size in 2020 and is further anticipated to maintain its leading position during the forecast period as well. This growth can be accredited to enhanced knowledge of understanding the patterns of protein expression for disease diagnostics and development of drug. Also, tandem mass spectrometry and liquid chromatography are some proteomics technologies that are effective for the identification of proteins, thus boosting the growth of the segment across the globe. Based on indication, the market is segmented into oncology, infectious disease, respiratory, cardiology, others. Out of which, infectious disease segment is expected to undergo the fastest CAGR during the forecast period due to the increasing incidence of infectious diseases.
Major players operating in the global proteomics market include Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Waters Corporation, Bio-Rad Laboratories, Inc., Danaher Corporation (SCIEX), GE Healthcare, Inc., PerkinElmer, Inc., Becton, Dickinson and Company, Illumina, Inc., Biocon Limited, Qiagen N.V., Bruker Corporation, Luminex Corporation, Evotec SE, Horiba, Ltd., Creative Proteomics, Promega Corporation, CellCarta Precision Medicine, Inc., Bioproximity LLC, Applied Biomics, Inc., etc. The companies operating in proteomics market across the globe are focusing more towards expanding their share in the market. Rising competitiveness is anticipated to drive innovation in the market, therefore helping the industry to solve existing challenges and meet the unmet needs in the market. Furthermore, the market players are focusing on R&D activities to enhance their product portfolios. Also, they are adopting strategies such as collaborations and acquisitions to further bolster their status in the proteomics market. For instance, many companies working with mass spectrometry and both the manufacturers and end-user labs are collaborating with protein chip-related companies.
Years considered for this report:
- Historical Years: 2016-2019
- Base Year: 2020
- Estimated Year: 2021E
- Forecast Period: 2022–2026F
- To analyze the historical growth in the market size of global proteomics market from 2016 to 2020.
- To estimate and forecast the market size of global proteomics market from 2021 to 2026 and growth rate until 2026.
- To classify and forecast global proteomics market based on application, indication, technology, type, product, end-user, company and regional distribution.
- To identify drivers and challenges for global proteomics market.
- To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global proteomics market.
- To conduct pricing analysis for global proteomics market.
- To identify and analyze the profile of leading players operating in global proteomics market.
TechSci Research calculated the market size of global proteomics market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.
Key Target Audience:
- Proteomics companies, suppliers, distributors and other stakeholders
- Government bodies such as regulating authorities and policy makers
- Organizations, forums and alliances related to proteomics
- Market research and consulting firms
Report Scope:
In this report, global proteomics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
- Global Proteomics Market, By Application:
- Clinical Diagnostic
- Drug Discovery
- Diagnostic Biomarker Discovery
- Others
- Global Proteomics Market, By Indication:
- Oncology
- Infectious Disease
- Respiratory
- Cardiology
- Others
- Global Proteomics Market, By Technology:
- Conventional
- Chromatography
- ELISA
- Western Blotting
- Advanced
- Protein Microarray
- Gel Electrophoresis
- Mass Spectrophotometry
- Edman Sequencing
- Quantitative
- Isotope-coded affinity tag (ICAT) labeling
- Stable isotope labeling with amino acids in cell culture (SILAC)
- Isobaric tag for relative and absolute quantitation (iTRAQ)
- High-throughput
- X-ray crystallography
- NMR
- Bioinformatic Analysis
- Global Proteomics Market, By Type:
- Expression
- Functional
- Structural
- Computational
- Global Proteomics Market, By Product:
- Reagents and Assays
- Instruments
- Software & Services
- Global Proteomics Market, By End-User:
- Pharmaceutical and Biotechnology Companies
- Research Institutes
- CROs
- Global Proteomics Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Asia-Pacific
- Japan
- China
- India
- South Korea
- Australia
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Company Profiles: Detailed analysis of the major companies present in global proteomics market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. PRODUCT OVERVIEW
2. RESEARCH METHODOLOGY
3. IMPACT OF COVID-19 ON GLOBAL PROTEOMICS MARKET
4. EXECUTIVE SUMMARY
5. VOICE OF CUSTOMER
5.1. Brand Awareness & Brand Recall
5.2. Factors Influencing Purchase Decision
5.3. Unmet Needs & Challenges
6. GLOBAL PROTEOMICS MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Application (Clinical Diagnostic, Drug Discovery, Diagnostic Biomarker Discovery, Others)
6.2.2. By Indication (Oncology, Infectious Disease, Respiratory, Cardiology, Others)
6.2.3. By Technology
6.2.3.1. Conventional (Chromatography, ELISA, Western blotting)
6.2.3.2. Advanced (Protein microarray, Gel electrophoresis, Mass Spectrophotometry, Edman Sequencing)
6.2.3.3. Quantitative (Isotope-coded affinity tag (ICAT) labeling, Stable isotope labeling with amino acids in cell culture (SILAC), Isobaric tag for relative and absolute quantitation (iTRAQ))
6.2.3.4. High-throughput (X-ray crystallography, NMR)
6.2.3.5. Bioinformatic analysis
6.2.4. By Type (Expression, Functional, Structural, Computational)
6.2.5. By Product (Reagents and Assays, Instruments, Software & Services)
6.2.6. By End-User (Pharmaceutical and Biotechnology Companies, Research Institutes, CROs)
6.2.7. By Company (2020)
6.2.8. By Region
6.3. Product Market Map
7. NORTH AMERICA PROTEOMICS MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Application
7.2.2. By Indication
7.2.3. By Technology
7.2.3.1. Conventional (Chromatography, ELISA, Western blotting)
7.2.3.2. Advanced (Protein microarray, Gel electrophoresis, Mass Spectrophotometry, Edman Sequencing)
7.2.3.3. Quantitative (Isotope-coded affinity tag (ICAT) labeling, Stable isotope labeling with amino acids in cell culture (SILAC), Isobaric tag for relative and absolute quantitation (iTRAQ))
7.2.3.4. High-throughput (X-ray crystallography, NMR)
7.2.3.5. Bioinformatic analysis
7.2.4. By Type
7.2.5. By Product
7.2.6. By End-User
7.2.7. By Country
7.3. North America: Country Analysis
7.3.1. United States Proteomics Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Application
7.3.1.2.2. By Indication
7.3.1.2.3. By Technology
7.3.1.2.4. By Type
7.3.1.2.5. By Product
7.3.1.2.6. By End-User
7.3.2. Canada Proteomics Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Application
7.3.2.2.2. By Indication
7.3.2.2.3. By Technology
7.3.2.2.4. By Type
7.3.2.2.5. By Product
7.3.2.2.6. By End-User
7.3.3. Mexico Proteomics Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Application
7.3.3.2.2. By Indication
7.3.3.2.3. By Technology
7.3.3.2.4. By Type
7.3.3.2.5. By Product
7.3.3.2.6. By End-User
8. EUROPE PROTEOMICS MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Application
8.2.2. By Indication
8.2.3. By Technology
8.2.3.1. Conventional (Chromatography, ELISA, Western blotting)
8.2.3.2. Advanced (Protein microarray, Gel electrophoresis, Mass Spectrophotometry, Edman Sequencing)
8.2.3.3. Quantitative (Isotope-coded affinity tag (ICAT) labeling, Stable isotope labeling with amino acids in cell culture (SILAC), Isobaric tag for relative and absolute quantitation (iTRAQ))
8.2.3.4. High-throughput (X-ray crystallography, NMR)
8.2.3.5. Bioinformatic analysis
8.2.4. By Type
8.2.5. By Product
8.2.6. By End-User
8.2.7. By Country
8.3. Europe: Country Analysis
8.3.1. Germany Proteomics Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Application
8.3.1.2.2. By Indication
8.3.1.2.3. By Technology
8.3.1.2.4. By Type
8.3.1.2.5. By Product
8.3.1.2.6. By End-User
8.3.2. United Kingdom Proteomics Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Application
8.3.2.2.2. By Indication
8.3.2.2.3. By Technology
8.3.2.2.4. By Type
8.3.2.2.5. By Product
8.3.2.2.6. By End-User
8.3.3. France Proteomics Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Application
8.3.3.2.2. By Indication
8.3.3.2.3. By Technology
8.3.3.2.4. By Type
8.3.3.2.5. By Product
8.3.3.2.6. By End-User
8.3.4. Italy Proteomics Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Application
8.3.4.2.2. By Indication
8.3.4.2.3. By Technology
8.3.4.2.4. By Type
8.3.4.2.5. By Product
8.3.4.2.6. By End-User
8.3.5. Spain Proteomics Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Application
8.3.5.2.2. By Indication
8.3.5.2.3. By Technology
8.3.5.2.4. By Type
8.3.5.2.5. By Product
8.3.5.2.6. By End-User
9. ASIA-PACIFIC PROTEOMICS MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Application
9.2.2. By Indication
9.2.3. By Technology
9.2.3.1. Conventional (Chromatography, ELISA, Western blotting)
9.2.3.2. Advanced (Protein microarray, Gel electrophoresis, Mass Spectrophotometry, Edman Sequencing)
9.2.3.3. Quantitative (Isotope-coded affinity tag (ICAT) labeling, Stable isotope labeling with amino acids in cell culture (SILAC), Isobaric tag for relative and absolute quantitation (iTRAQ))
9.2.3.4. High-throughput (X-ray crystallography, NMR)
9.2.3.5. Bioinformatic analysis
9.2.4. By Type
9.2.5. By Product
9.2.6. By End-User
9.2.7. By Country
9.3. Asia-Pacific: Country Analysis
9.3.1. Japan Proteomics Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Application
9.3.1.2.2. By Indication
9.3.1.2.3. By Technology
9.3.1.2.4. By Type
9.3.1.2.5. By Product
9.3.1.2.6. By End-User
9.3.2. China Proteomics Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Application
9.3.2.2.2. By Indication
9.3.2.2.3. By Technology
9.3.2.2.4. By Type
9.3.2.2.5. By Product
9.3.2.2.6. By End-User
9.3.3. India Proteomics Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Application
9.3.3.2.2. By Indication
9.3.3.2.3. By Technology
9.3.3.2.4. By Type
9.3.3.2.5. By Product
9.3.3.2.6. By End-User
9.3.4. South Korea Proteomics Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Application
9.3.4.2.2. By Indication
9.3.4.2.3. By Technology
9.3.4.2.4. By Type
9.3.4.2.5. By Product
9.3.4.2.6. By End-User
9.3.5. Australia Proteomics Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Application
9.3.5.2.2. By Indication
9.3.5.2.3. By Technology
9.3.5.2.4. By Type
9.3.5.2.5. By Product
9.3.5.2.6. By End-User
10. SOUTH AMERICA PROTEOMICS MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Application
10.2.2. By Indication
10.2.3. By Technology
10.2.3.1. Conventional (Chromatography, ELISA, Western blotting)
10.2.3.2. Advanced (Protein microarray, Gel electrophoresis, Mass Spectrophotometry, Edman Sequencing)
10.2.3.3. Quantitative (Isotope-coded affinity tag (ICAT) labeling, Stable isotope labeling with amino acids in cell culture (SILAC), Isobaric tag for relative and absolute quantitation (iTRAQ))
10.2.3.4. High-throughput (X-ray crystallography, NMR)
10.2.3.5. Bioinformatic analysis
10.2.4. By Type
10.2.5. By Product
10.2.6. By End-User
10.2.7. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Proteomics Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Application
10.3.1.2.2. By Indication
10.3.1.2.3. By Technology
10.3.1.2.4. By Type
10.3.1.2.5. By Product
10.3.1.2.6. By End-User
10.3.2. Argentina Proteomics Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Application
10.3.2.2.2. By Indication
10.3.2.2.3. By Technology
10.3.2.2.4. By Type
10.3.2.2.5. By Product
10.3.2.2.6. By End-User
10.3.3. Colombia Proteomics Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Application
10.3.3.2.2. By Indication
10.3.3.2.3. By Technology
10.3.3.2.4. By Type
10.3.3.2.5. By Product
10.3.3.2.6. By End-User
11. MIDDLE EAST & AFRICA PROTEOMICS MARKET OUTLOOK
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Application
11.2.2. By Indication
11.2.3. By Technology
11.2.3.1. Conventional (Chromatography, ELISA, Western blotting)
11.2.3.2. Advanced (Protein microarray, Gel electrophoresis, Mass Spectrophotometry, Edman Sequencing)
11.2.3.3. Quantitative (Isotope-coded affinity tag (ICAT) labeling, Stable isotope labeling with amino acids in cell culture (SILAC), Isobaric tag for relative and absolute quantitation (iTRAQ))
11.2.3.4. High-throughput (X-ray crystallography, NMR)
11.2.3.5. Bioinformatic analysis
11.2.4. By Type
11.2.5. By Product
11.2.6. By End-User
11.2.7. By Country
11.3. Middle East & Africa: Country Analysis
11.3.1. South Africa Proteomics Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Application
11.3.1.2.2. By Indication
11.3.1.2.3. By Technology
11.3.1.2.4. By Type
11.3.1.2.5. By Product
11.3.1.2.6. By End-User
11.3.2. Saudi Arabia Proteomics Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Application
11.3.2.2.2. By Indication
11.3.2.2.3. By Technology
11.3.2.2.4. By Type
11.3.2.2.5. By Product
11.3.2.2.6. By End-User
11.3.3. UAE Proteomics Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Application
11.3.3.2.2. By Indication
11.3.3.2.3. By Technology
11.3.3.2.4. By Type
11.3.3.2.5. By Product
11.3.3.2.6. By End-User
12. MARKET DYNAMICS
12.1. Drivers
12.2. Challenges
13. MARKET TRENDS & DEVELOPMENTS
14. COMPETITIVE LANDSCAPE
14.1. Competition Outlook
14.2. Players Profiled (Leading Companies)
14.2.1. Thermo Fisher Scientific, Inc.
14.2.2. Agilent Technologies, Inc.
14.2.3. Waters Corporation
14.2.4. Bio-Rad Laboratories, Inc.
14.2.5. Danaher Corporation (SCIEX)
14.2.6. GE Healthcare, Inc.
14.2.7. PerkinElmer, Inc.
14.2.8. Becton, Dickinson and Company
14.2.9. Illumina, Inc.
14.2.10. Biocon Limited
14.2.11. Qiagen N.V.
14.2.12. Bruker Corporation
14.2.13. Luminex Corporation
14.2.14. Evotec SE
14.2.15. Horiba, Ltd.
14.2.16. Creative Proteomics
14.2.17. Promega Corporation
14.2.18. CellCarta Precision Medicine, Inc.
14.2.19. Bioproximity LLC
14.2.20. Applied Biomics, Inc.
15. STRATEGIC RECOMMENDATIONS
16. ABOUT US & DISCLAIMER
2. RESEARCH METHODOLOGY
3. IMPACT OF COVID-19 ON GLOBAL PROTEOMICS MARKET
4. EXECUTIVE SUMMARY
5. VOICE OF CUSTOMER
5.1. Brand Awareness & Brand Recall
5.2. Factors Influencing Purchase Decision
5.3. Unmet Needs & Challenges
6. GLOBAL PROTEOMICS MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Application (Clinical Diagnostic, Drug Discovery, Diagnostic Biomarker Discovery, Others)
6.2.2. By Indication (Oncology, Infectious Disease, Respiratory, Cardiology, Others)
6.2.3. By Technology
6.2.3.1. Conventional (Chromatography, ELISA, Western blotting)
6.2.3.2. Advanced (Protein microarray, Gel electrophoresis, Mass Spectrophotometry, Edman Sequencing)
6.2.3.3. Quantitative (Isotope-coded affinity tag (ICAT) labeling, Stable isotope labeling with amino acids in cell culture (SILAC), Isobaric tag for relative and absolute quantitation (iTRAQ))
6.2.3.4. High-throughput (X-ray crystallography, NMR)
6.2.3.5. Bioinformatic analysis
6.2.4. By Type (Expression, Functional, Structural, Computational)
6.2.5. By Product (Reagents and Assays, Instruments, Software & Services)
6.2.6. By End-User (Pharmaceutical and Biotechnology Companies, Research Institutes, CROs)
6.2.7. By Company (2020)
6.2.8. By Region
6.3. Product Market Map
7. NORTH AMERICA PROTEOMICS MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Application
7.2.2. By Indication
7.2.3. By Technology
7.2.3.1. Conventional (Chromatography, ELISA, Western blotting)
7.2.3.2. Advanced (Protein microarray, Gel electrophoresis, Mass Spectrophotometry, Edman Sequencing)
7.2.3.3. Quantitative (Isotope-coded affinity tag (ICAT) labeling, Stable isotope labeling with amino acids in cell culture (SILAC), Isobaric tag for relative and absolute quantitation (iTRAQ))
7.2.3.4. High-throughput (X-ray crystallography, NMR)
7.2.3.5. Bioinformatic analysis
7.2.4. By Type
7.2.5. By Product
7.2.6. By End-User
7.2.7. By Country
7.3. North America: Country Analysis
7.3.1. United States Proteomics Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Application
7.3.1.2.2. By Indication
7.3.1.2.3. By Technology
7.3.1.2.4. By Type
7.3.1.2.5. By Product
7.3.1.2.6. By End-User
7.3.2. Canada Proteomics Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Application
7.3.2.2.2. By Indication
7.3.2.2.3. By Technology
7.3.2.2.4. By Type
7.3.2.2.5. By Product
7.3.2.2.6. By End-User
7.3.3. Mexico Proteomics Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Application
7.3.3.2.2. By Indication
7.3.3.2.3. By Technology
7.3.3.2.4. By Type
7.3.3.2.5. By Product
7.3.3.2.6. By End-User
8. EUROPE PROTEOMICS MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Application
8.2.2. By Indication
8.2.3. By Technology
8.2.3.1. Conventional (Chromatography, ELISA, Western blotting)
8.2.3.2. Advanced (Protein microarray, Gel electrophoresis, Mass Spectrophotometry, Edman Sequencing)
8.2.3.3. Quantitative (Isotope-coded affinity tag (ICAT) labeling, Stable isotope labeling with amino acids in cell culture (SILAC), Isobaric tag for relative and absolute quantitation (iTRAQ))
8.2.3.4. High-throughput (X-ray crystallography, NMR)
8.2.3.5. Bioinformatic analysis
8.2.4. By Type
8.2.5. By Product
8.2.6. By End-User
8.2.7. By Country
8.3. Europe: Country Analysis
8.3.1. Germany Proteomics Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Application
8.3.1.2.2. By Indication
8.3.1.2.3. By Technology
8.3.1.2.4. By Type
8.3.1.2.5. By Product
8.3.1.2.6. By End-User
8.3.2. United Kingdom Proteomics Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Application
8.3.2.2.2. By Indication
8.3.2.2.3. By Technology
8.3.2.2.4. By Type
8.3.2.2.5. By Product
8.3.2.2.6. By End-User
8.3.3. France Proteomics Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Application
8.3.3.2.2. By Indication
8.3.3.2.3. By Technology
8.3.3.2.4. By Type
8.3.3.2.5. By Product
8.3.3.2.6. By End-User
8.3.4. Italy Proteomics Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Application
8.3.4.2.2. By Indication
8.3.4.2.3. By Technology
8.3.4.2.4. By Type
8.3.4.2.5. By Product
8.3.4.2.6. By End-User
8.3.5. Spain Proteomics Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Application
8.3.5.2.2. By Indication
8.3.5.2.3. By Technology
8.3.5.2.4. By Type
8.3.5.2.5. By Product
8.3.5.2.6. By End-User
9. ASIA-PACIFIC PROTEOMICS MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Application
9.2.2. By Indication
9.2.3. By Technology
9.2.3.1. Conventional (Chromatography, ELISA, Western blotting)
9.2.3.2. Advanced (Protein microarray, Gel electrophoresis, Mass Spectrophotometry, Edman Sequencing)
9.2.3.3. Quantitative (Isotope-coded affinity tag (ICAT) labeling, Stable isotope labeling with amino acids in cell culture (SILAC), Isobaric tag for relative and absolute quantitation (iTRAQ))
9.2.3.4. High-throughput (X-ray crystallography, NMR)
9.2.3.5. Bioinformatic analysis
9.2.4. By Type
9.2.5. By Product
9.2.6. By End-User
9.2.7. By Country
9.3. Asia-Pacific: Country Analysis
9.3.1. Japan Proteomics Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Application
9.3.1.2.2. By Indication
9.3.1.2.3. By Technology
9.3.1.2.4. By Type
9.3.1.2.5. By Product
9.3.1.2.6. By End-User
9.3.2. China Proteomics Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Application
9.3.2.2.2. By Indication
9.3.2.2.3. By Technology
9.3.2.2.4. By Type
9.3.2.2.5. By Product
9.3.2.2.6. By End-User
9.3.3. India Proteomics Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Application
9.3.3.2.2. By Indication
9.3.3.2.3. By Technology
9.3.3.2.4. By Type
9.3.3.2.5. By Product
9.3.3.2.6. By End-User
9.3.4. South Korea Proteomics Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Application
9.3.4.2.2. By Indication
9.3.4.2.3. By Technology
9.3.4.2.4. By Type
9.3.4.2.5. By Product
9.3.4.2.6. By End-User
9.3.5. Australia Proteomics Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Application
9.3.5.2.2. By Indication
9.3.5.2.3. By Technology
9.3.5.2.4. By Type
9.3.5.2.5. By Product
9.3.5.2.6. By End-User
10. SOUTH AMERICA PROTEOMICS MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Application
10.2.2. By Indication
10.2.3. By Technology
10.2.3.1. Conventional (Chromatography, ELISA, Western blotting)
10.2.3.2. Advanced (Protein microarray, Gel electrophoresis, Mass Spectrophotometry, Edman Sequencing)
10.2.3.3. Quantitative (Isotope-coded affinity tag (ICAT) labeling, Stable isotope labeling with amino acids in cell culture (SILAC), Isobaric tag for relative and absolute quantitation (iTRAQ))
10.2.3.4. High-throughput (X-ray crystallography, NMR)
10.2.3.5. Bioinformatic analysis
10.2.4. By Type
10.2.5. By Product
10.2.6. By End-User
10.2.7. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Proteomics Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Application
10.3.1.2.2. By Indication
10.3.1.2.3. By Technology
10.3.1.2.4. By Type
10.3.1.2.5. By Product
10.3.1.2.6. By End-User
10.3.2. Argentina Proteomics Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Application
10.3.2.2.2. By Indication
10.3.2.2.3. By Technology
10.3.2.2.4. By Type
10.3.2.2.5. By Product
10.3.2.2.6. By End-User
10.3.3. Colombia Proteomics Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Application
10.3.3.2.2. By Indication
10.3.3.2.3. By Technology
10.3.3.2.4. By Type
10.3.3.2.5. By Product
10.3.3.2.6. By End-User
11. MIDDLE EAST & AFRICA PROTEOMICS MARKET OUTLOOK
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Application
11.2.2. By Indication
11.2.3. By Technology
11.2.3.1. Conventional (Chromatography, ELISA, Western blotting)
11.2.3.2. Advanced (Protein microarray, Gel electrophoresis, Mass Spectrophotometry, Edman Sequencing)
11.2.3.3. Quantitative (Isotope-coded affinity tag (ICAT) labeling, Stable isotope labeling with amino acids in cell culture (SILAC), Isobaric tag for relative and absolute quantitation (iTRAQ))
11.2.3.4. High-throughput (X-ray crystallography, NMR)
11.2.3.5. Bioinformatic analysis
11.2.4. By Type
11.2.5. By Product
11.2.6. By End-User
11.2.7. By Country
11.3. Middle East & Africa: Country Analysis
11.3.1. South Africa Proteomics Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Application
11.3.1.2.2. By Indication
11.3.1.2.3. By Technology
11.3.1.2.4. By Type
11.3.1.2.5. By Product
11.3.1.2.6. By End-User
11.3.2. Saudi Arabia Proteomics Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Application
11.3.2.2.2. By Indication
11.3.2.2.3. By Technology
11.3.2.2.4. By Type
11.3.2.2.5. By Product
11.3.2.2.6. By End-User
11.3.3. UAE Proteomics Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Application
11.3.3.2.2. By Indication
11.3.3.2.3. By Technology
11.3.3.2.4. By Type
11.3.3.2.5. By Product
11.3.3.2.6. By End-User
12. MARKET DYNAMICS
12.1. Drivers
12.2. Challenges
13. MARKET TRENDS & DEVELOPMENTS
14. COMPETITIVE LANDSCAPE
14.1. Competition Outlook
14.2. Players Profiled (Leading Companies)
14.2.1. Thermo Fisher Scientific, Inc.
14.2.2. Agilent Technologies, Inc.
14.2.3. Waters Corporation
14.2.4. Bio-Rad Laboratories, Inc.
14.2.5. Danaher Corporation (SCIEX)
14.2.6. GE Healthcare, Inc.
14.2.7. PerkinElmer, Inc.
14.2.8. Becton, Dickinson and Company
14.2.9. Illumina, Inc.
14.2.10. Biocon Limited
14.2.11. Qiagen N.V.
14.2.12. Bruker Corporation
14.2.13. Luminex Corporation
14.2.14. Evotec SE
14.2.15. Horiba, Ltd.
14.2.16. Creative Proteomics
14.2.17. Promega Corporation
14.2.18. CellCarta Precision Medicine, Inc.
14.2.19. Bioproximity LLC
14.2.20. Applied Biomics, Inc.
15. STRATEGIC RECOMMENDATIONS
16. ABOUT US & DISCLAIMER
LIST OF FIGURES
Figure 1: Global Proteomics Market Size, By Value (USD Billion), 2016-2026F
Figure 2: Global Proteomics Market Share, By Application, By Value, 2016-2026F
Figure 3: Global Proteomics Market Share, By Indication, By Value, 2016-2026F
Figure 4: Global Proteomics Market Share, By Technology, By Value, 2016-2026F
Figure 5: Global Proteomics Market Share, By Technology, By Conventional, By Value, 2016-2026F
Figure 6: Global Proteomics Market Share, By Technology, By Advanced, By Value, 2016-2026F
Figure 7: Global Proteomics Market Share, By Technology, By Quantitative, By Value, 2016-2026F
Figure 8: Global Proteomics Market Share, By Technology, By High-throughput, By Value, 2016-2026F
Figure 9: Global Proteomics Market Share, By Type, By Value, 2016-2026F
Figure 10: Global Proteomics Market Share, By Product, By Value, 2016-2026F
Figure 11: Global Proteomics Market Share, By End User, By Value, 2016-2026F
Figure 12: Global Proteomics Market Share, By Company, 2016-2026F
Figure 13: Global Proteomics Market Share, By Region, 2016-2026F
Figure 14: Global Proteomics Market, By Product Market Map, 2016-2026F
Figure 15: North America Proteomics Market Size, By Value (USD Billion), 2016-2026F
Figure 16: North America Proteomics Market Share, By Application, By Value, 2016-2026F
Figure 17: North America Proteomics Market Share, By Indication, By Value, 2016-2026F
Figure 18: North America Proteomics Market Share, By Technology, By Value, 2016-2026F
Figure 19: North America Proteomics Market Share, By Technology, By Conventional, By Value, 2016-2026F
Figure 20: North America Proteomics Market Share, By Technology, By Advanced, By Value, 2016-2026F
Figure 21: North America Proteomics Market Share, By Technology, By Quantitative, By Value, 2016-2026F
Figure 22: North America Proteomics Market Share, By Technology, By High-throughput, By Value, 2016-2026F
Figure 23: North America Proteomics Market Share, By Type, By Value, 2016-2026F
Figure 24: North America Proteomics Market Share, By Product, By Value, 2016-2026F
Figure 25: North America Proteomics Market Share, By End User, By Value, 2016-2026F
Figure 26: North America Proteomics Market Share, By Country, By Value, 2016-2026F
Figure 27: United States Proteomics Market Size, By Value (USD Billion), 2016-2026F
Figure 28: United States Proteomics Market Share, By Application, By Value, 2016-2026F
Figure 29: United States Proteomics Market Share, By Indication, By Value, 2016-2026F
Figure 30: United States Proteomics Market Share, By Technology, By Value, 2016-2026F
Figure 31: United States Proteomics Market Share, By Type, By Value, 2016-2026F
Figure 32: United States Proteomics Market Share, By Product, By Value, 2016-2026F
Figure 33: United States Proteomics Market Share, By End User, By Value, 2016-2026F
Figure 34: Canada Proteomics Market Size, By Value (USD Billion), 2016-2026F
Figure 35: Canada Proteomics Market Share, By Application, By Value, 2016-2026F
Figure 36: Canada Proteomics Market Share, By Indication, By Value, 2016-2026F
Figure 37: Canada Proteomics Market Share, By Technology, By Value, 2016-2026F
Figure 38: Canada Proteomics Market Share, By Type, By Value, 2016-2026F
Figure 39: Canada Proteomics Market Share, By Product, By Value, 2016-2026F
Figure 40: Canada Proteomics Market Share, By End User, By Value, 2016-2026F
Figure 41: Mexico Proteomics Market Size, By Value (USD Billion), 2016-2026F
Figure 42: Mexico Proteomics Market Share, By Application, By Value, 2016-2026F
Figure 43: Mexico Proteomics Market Share, By Indication, By Value, 2016-2026F
Figure 44: Mexico Proteomics Market Share, By Technology, By Value, 2016-2026F
Figure 45: Mexico Proteomics Market Share, By Type, By Value, 2016-2026F
Figure 46: Mexico Proteomics Market Share, By Product, By Value, 2016-2026F
Figure 47: Mexico Proteomics Market Share, By End User, By Value, 2016-2026F
Figure 48: Europe Proteomics Market Size, By Value (USD Billion), 2016-2026F
Figure 49: Europe Proteomics Market Share, By Application, By Value, 2016-2026F
Figure 50: Europe Proteomics Market Share, By Indication, By Value, 2016-2026F
Figure 51: Europe Proteomics Market Share, By Technology, By Value, 2016-2026F
Figure 52: Europe Proteomics Market Share, By Technology, By Conventional, By Value, 2016-2026F
Figure 53: Europe Proteomics Market Share, By Technology, By Advanced, By Value, 2016-2026F
Figure 54: Europe Proteomics Market Share, By Technology, By Quantitative, By Value, 2016-2026F
Figure 55: Europe Proteomics Market Share, By Technology, By High-throughput, By Value, 2016-2026F
Figure 56: Europe Proteomics Market Share, By Type, By Value, 2016-2026F
Figure 57: Europe Proteomics Market Share, By Product, By Value, 2016-2026F
Figure 58: Europe Proteomics Market Share, By End User, By Value, 2016-2026F
Figure 59: Europe Proteomics Market Share, By Country, By Value, 2016-2026F
Figure 60: Germany Proteomics Market Size, By Value (USD Billion), 2016-2026F
Figure 61: Germany Proteomics Market Share, By Application, By Value, 2016-2026F
Figure 62: Germany Proteomics Market Share, By Indication, By Value, 2016-2026F
Figure 63: Germany Proteomics Market Share, By Technology, By Value, 2016-2026F
Figure 64: Germany Proteomics Market Share, By Type, By Value, 2016-2026F
Figure 65: Germany Proteomics Market Share, By Product, By Value, 2016-2026F
Figure 66: Germany Proteomics Market Share, By End User, By Value, 2016-2026F
Figure 67: United Kingdom Proteomics Market Size, By Value (USD Billion), 2016-2026F
Figure 68: United Kingdom Proteomics Market Share, By Application, By Value, 2016-2026F
Figure 69: United Kingdom Proteomics Market Share, By Indication, By Value, 2016-2026F
Figure 70: United Kingdom Proteomics Market Share, By Technology, By Value, 2016-2026F
Figure 71: United Kingdom Proteomics Market Share, By Type, By Value, 2016-2026F
Figure 72: United Kingdom Proteomics Market Share, By Product, By Value, 2016-2026F
Figure 73: United Kingdom Proteomics Market Share, By End User, By Value, 2016-2026F
Figure 74: France Proteomics Market Size, By Value (USD Billion), 2016-2026F
Figure 75: France Proteomics Market Share, By Application, By Value, 2016-2026F
Figure 76: France Proteomics Market Share, By Indication, By Value, 2016-2026F
Figure 77: France Proteomics Market Share, By Technology, By Value, 2016-2026F
Figure 78: France Proteomics Market Share, By Type, By Value, 2016-2026F
Figure 79: France Proteomics Market Share, By Product, By Value, 2016-2026F
Figure 80: France Proteomics Market Share, By End User, By Value, 2016-2026F
Figure 81: Italy Proteomics Market Size, By Value (USD Billion), 2016-2026F
Figure 82: Italy Proteomics Market Share, By Application, By Value, 2016-2026F
Figure 83: Italy Proteomics Market Share, By Indication, By Value, 2016-2026F
Figure 84: Italy Proteomics Market Share, By Technology, By Value, 2016-2026F
Figure 85: Italy Proteomics Market Share, By Type, By Value, 2016-2026F
Figure 86: Italy Proteomics Market Share, By Product, By Value, 2016-2026F
Figure 87: Italy Proteomics Market Share, By End User, By Value, 2016-2026F
Figure 88: Spain Proteomics Market Size, By Value (USD Billion), 2016-2026F
Figure 89: Spain Proteomics Market Share, By Application, By Value, 2016-2026F
Figure 90: Spain Proteomics Market Share, By Indication, By Value, 2016-2026F
Figure 91: Spain Proteomics Market Share, By Technology, By Value, 2016-2026F
Figure 92: Spain Proteomics Market Share, By Type, By Value, 2016-2026F
Figure 93: Spain Proteomics Market Share, By Product, By Value, 2016-2026F
Figure 94: Spain Proteomics Market Share, By End User, By Value, 2016-2026F
Figure 95: Asia-Pacific Proteomics Market Size, By Value (USD Billion), 2016-2026F
Figure 96: Asia-Pacific Proteomics Market Share, By Application, By Value, 2016-2026F
Figure 97: Asia-Pacific Proteomics Market Share, By Indication, By Value, 2016-2026F
Figure 98: Asia-Pacific Proteomics Market Share, By Technology, By Value, 2016-2026F
Figure 99: Asia-Pacific Proteomics Market Share, By Technology, By Conventional, By Value, 2016-2026F
Figure 100: Asia-Pacific Proteomics Market Share, By Technology, By Advanced, By Value, 2016-2026F
Figure 101: Asia-Pacific Proteomics Market Share, By Technology, By Quantitative, By Value, 2016-2026F
Figure 102: Asia-Pacific Proteomics Market Share, By Technology, By High-throughput, By Value, 2016-2026F
Figure 103: Asia-Pacific Proteomics Market Share, By Type, By Value, 2016-2026F
Figure 104: Asia-Pacific Proteomics Market Share, By Product, By Value, 2016-2026F
Figure 105: Asia-Pacific Proteomics Market Share, By End User, By Value, 2016-2026F
Figure 106: Asia-Pacific Proteomics Market Share, By Country, By Value, 2016-2026F
Figure 107: Japan Proteomics Market Size, By Value (USD Billion), 2016-2026F
Figure 108: Japan Proteomics Market Share, By Application, By Value, 2016-2026F
Figure 109: Japan Proteomics Market Share, By Indication, By Value, 2016-2026F
Figure 110: Japan Proteomics Market Share, By Technology, By Value, 2016-2026F
Figure 111: Japan Proteomics Market Share, By Type, By Value, 2016-2026F
Figure 112: Japan Proteomics Market Share, By Product, By Value, 2016-2026F
Figure 113: Japan Proteomics Market Share, By End User, By Value, 2016-2026F
Figure 114: China Proteomics Market Size, By Value (USD Billion), 2016-2026F
Figure 115: China Proteomics Market Share, By Application, By Value, 2016-2026F
Figure 116: China Proteomics Market Share, By Indication, By Value, 2016-2026F
Figure 117: China Proteomics Market Share, By Technology, By Value, 2016-2026F
Figure 118: China Proteomics Market Share, By Type, By Value, 2016-2026F
Figure 119: China Proteomics Market Share, By Product, By Value, 2016-2026F
Figure 120: China Proteomics Market Share, By End User, By Value, 2016-2026F
Figure 121: India Proteomics Market Size, By Value (USD Billion), 2016-2026F
Figure 122: India Proteomics Market Share, By Application, By Value, 2016-2026F
Figure 123: India Proteomics Market Share, By Indication, By Value, 2016-2026F
Figure 124: India Proteomics Market Share, By Technology, By Value, 2016-2026F
Figure 125: India Proteomics Market Share, By Type, By Value, 2016-2026F
Figure 126: India Proteomics Market Share, By Product, By Value, 2016-2026F
Figure 127: India Proteomics Market Share, By End User, By Value, 2016-2026F
Figure 128: South Korea Proteomics Market Size, By Value (USD Billion), 2016-2026F
Figure 129: South Korea Proteomics Market Share, By Application, By Value, 2016-2026F
Figure 130: South Korea Proteomics Market Share, By Indication, By Value, 2016-2026F
Figure 131: South Korea Proteomics Market Share, By Technology, By Value, 2016-2026F
Figure 132: South Korea Proteomics Market Share, By Type, By Value, 2016-2026F
Figure 133: South Korea Proteomics Market Share, By Product, By Value, 2016-2026F
Figure 134: South Korea Proteomics Market Share, By End User, By Value, 2016-2026F
Figure 135: Australia Proteomics Market Size, By Value (USD Billion), 2016-2026F
Figure 136: Australia Proteomics Market Share, By Application, By Value, 2016-2026F
Figure 137: Australia Proteomics Market Share, By Indication, By Value, 2016-2026F
Figure 138: Australia Proteomics Market Share, By Technology, By Value, 2016-2026F
Figure 139: Australia Proteomics Market Share, By Type, By Value, 2016-2026F
Figure 140: Australia Proteomics Market Share, By Product, By Value, 2016-2026F
Figure 141: Australia Proteomics Market Share, By End User, By Value, 2016-2026F
Figure 142: South America Proteomics Market Size, By Value (USD Billion), 2016-2026F
Figure 143: South America Proteomics Market Share, By Application, By Value, 2016-2026F
Figure 144: South America Proteomics Market Share, By Indication, By Value, 2016-2026F
Figure 145: South America Proteomics Market Share, By Technology, By Value, 2016-2026F
Figure 146: South America Proteomics Market Share, By Technology, By Conventional, By Value, 2016-2026F
Figure 147: South America Proteomics Market Share, By Technology, By Advanced, By Value, 2016-2026F
Figure 148: South America Proteomics Market Share, By Technology, By Quantitative, By Value, 2016-2026F
Figure 149: South America Proteomics Market Share, By Technology, By High-throughput, By Value, 2016-2026F
Figure 150: South America Proteomics Market Share, By Type, By Value, 2016-2026F
Figure 151: South America Proteomics Market Share, By Product, By Value, 2016-2026F
Figure 152: South America Proteomics Market Share, By End User, By Value, 2016-2026F
Figure 153: South America Proteomics Market Share, By Country, By Value, 2016-2026F
Figure 154: Brazil Proteomics Market Size, By Value (USD Billion), 2016-2026F
Figure 155: Brazil Proteomics Market Share, By Application, By Value, 2016-2026F
Figure 156: Brazil Proteomics Market Share, By Indication, By Value, 2016-2026F
Figure 157: Brazil Proteomics Market Share, By Technology, By Value, 2016-2026F
Figure 158: Brazil Proteomics Market Share, By Type, By Value, 2016-2026F
Figure 159: Brazil Proteomics Market Share, By Product, By Value, 2016-2026F
Figure 160: Brazil Proteomics Market Share, By End User, By Value, 2016-2026F
Figure 161: Argentina Proteomics Market Size, By Value (USD Billion), 2016-2026F
Figure 162: Argentina Proteomics Market Share, By Application, By Value, 2016-2026F
Figure 163: Argentina Proteom
Figure 1: Global Proteomics Market Size, By Value (USD Billion), 2016-2026F
Figure 2: Global Proteomics Market Share, By Application, By Value, 2016-2026F
Figure 3: Global Proteomics Market Share, By Indication, By Value, 2016-2026F
Figure 4: Global Proteomics Market Share, By Technology, By Value, 2016-2026F
Figure 5: Global Proteomics Market Share, By Technology, By Conventional, By Value, 2016-2026F
Figure 6: Global Proteomics Market Share, By Technology, By Advanced, By Value, 2016-2026F
Figure 7: Global Proteomics Market Share, By Technology, By Quantitative, By Value, 2016-2026F
Figure 8: Global Proteomics Market Share, By Technology, By High-throughput, By Value, 2016-2026F
Figure 9: Global Proteomics Market Share, By Type, By Value, 2016-2026F
Figure 10: Global Proteomics Market Share, By Product, By Value, 2016-2026F
Figure 11: Global Proteomics Market Share, By End User, By Value, 2016-2026F
Figure 12: Global Proteomics Market Share, By Company, 2016-2026F
Figure 13: Global Proteomics Market Share, By Region, 2016-2026F
Figure 14: Global Proteomics Market, By Product Market Map, 2016-2026F
Figure 15: North America Proteomics Market Size, By Value (USD Billion), 2016-2026F
Figure 16: North America Proteomics Market Share, By Application, By Value, 2016-2026F
Figure 17: North America Proteomics Market Share, By Indication, By Value, 2016-2026F
Figure 18: North America Proteomics Market Share, By Technology, By Value, 2016-2026F
Figure 19: North America Proteomics Market Share, By Technology, By Conventional, By Value, 2016-2026F
Figure 20: North America Proteomics Market Share, By Technology, By Advanced, By Value, 2016-2026F
Figure 21: North America Proteomics Market Share, By Technology, By Quantitative, By Value, 2016-2026F
Figure 22: North America Proteomics Market Share, By Technology, By High-throughput, By Value, 2016-2026F
Figure 23: North America Proteomics Market Share, By Type, By Value, 2016-2026F
Figure 24: North America Proteomics Market Share, By Product, By Value, 2016-2026F
Figure 25: North America Proteomics Market Share, By End User, By Value, 2016-2026F
Figure 26: North America Proteomics Market Share, By Country, By Value, 2016-2026F
Figure 27: United States Proteomics Market Size, By Value (USD Billion), 2016-2026F
Figure 28: United States Proteomics Market Share, By Application, By Value, 2016-2026F
Figure 29: United States Proteomics Market Share, By Indication, By Value, 2016-2026F
Figure 30: United States Proteomics Market Share, By Technology, By Value, 2016-2026F
Figure 31: United States Proteomics Market Share, By Type, By Value, 2016-2026F
Figure 32: United States Proteomics Market Share, By Product, By Value, 2016-2026F
Figure 33: United States Proteomics Market Share, By End User, By Value, 2016-2026F
Figure 34: Canada Proteomics Market Size, By Value (USD Billion), 2016-2026F
Figure 35: Canada Proteomics Market Share, By Application, By Value, 2016-2026F
Figure 36: Canada Proteomics Market Share, By Indication, By Value, 2016-2026F
Figure 37: Canada Proteomics Market Share, By Technology, By Value, 2016-2026F
Figure 38: Canada Proteomics Market Share, By Type, By Value, 2016-2026F
Figure 39: Canada Proteomics Market Share, By Product, By Value, 2016-2026F
Figure 40: Canada Proteomics Market Share, By End User, By Value, 2016-2026F
Figure 41: Mexico Proteomics Market Size, By Value (USD Billion), 2016-2026F
Figure 42: Mexico Proteomics Market Share, By Application, By Value, 2016-2026F
Figure 43: Mexico Proteomics Market Share, By Indication, By Value, 2016-2026F
Figure 44: Mexico Proteomics Market Share, By Technology, By Value, 2016-2026F
Figure 45: Mexico Proteomics Market Share, By Type, By Value, 2016-2026F
Figure 46: Mexico Proteomics Market Share, By Product, By Value, 2016-2026F
Figure 47: Mexico Proteomics Market Share, By End User, By Value, 2016-2026F
Figure 48: Europe Proteomics Market Size, By Value (USD Billion), 2016-2026F
Figure 49: Europe Proteomics Market Share, By Application, By Value, 2016-2026F
Figure 50: Europe Proteomics Market Share, By Indication, By Value, 2016-2026F
Figure 51: Europe Proteomics Market Share, By Technology, By Value, 2016-2026F
Figure 52: Europe Proteomics Market Share, By Technology, By Conventional, By Value, 2016-2026F
Figure 53: Europe Proteomics Market Share, By Technology, By Advanced, By Value, 2016-2026F
Figure 54: Europe Proteomics Market Share, By Technology, By Quantitative, By Value, 2016-2026F
Figure 55: Europe Proteomics Market Share, By Technology, By High-throughput, By Value, 2016-2026F
Figure 56: Europe Proteomics Market Share, By Type, By Value, 2016-2026F
Figure 57: Europe Proteomics Market Share, By Product, By Value, 2016-2026F
Figure 58: Europe Proteomics Market Share, By End User, By Value, 2016-2026F
Figure 59: Europe Proteomics Market Share, By Country, By Value, 2016-2026F
Figure 60: Germany Proteomics Market Size, By Value (USD Billion), 2016-2026F
Figure 61: Germany Proteomics Market Share, By Application, By Value, 2016-2026F
Figure 62: Germany Proteomics Market Share, By Indication, By Value, 2016-2026F
Figure 63: Germany Proteomics Market Share, By Technology, By Value, 2016-2026F
Figure 64: Germany Proteomics Market Share, By Type, By Value, 2016-2026F
Figure 65: Germany Proteomics Market Share, By Product, By Value, 2016-2026F
Figure 66: Germany Proteomics Market Share, By End User, By Value, 2016-2026F
Figure 67: United Kingdom Proteomics Market Size, By Value (USD Billion), 2016-2026F
Figure 68: United Kingdom Proteomics Market Share, By Application, By Value, 2016-2026F
Figure 69: United Kingdom Proteomics Market Share, By Indication, By Value, 2016-2026F
Figure 70: United Kingdom Proteomics Market Share, By Technology, By Value, 2016-2026F
Figure 71: United Kingdom Proteomics Market Share, By Type, By Value, 2016-2026F
Figure 72: United Kingdom Proteomics Market Share, By Product, By Value, 2016-2026F
Figure 73: United Kingdom Proteomics Market Share, By End User, By Value, 2016-2026F
Figure 74: France Proteomics Market Size, By Value (USD Billion), 2016-2026F
Figure 75: France Proteomics Market Share, By Application, By Value, 2016-2026F
Figure 76: France Proteomics Market Share, By Indication, By Value, 2016-2026F
Figure 77: France Proteomics Market Share, By Technology, By Value, 2016-2026F
Figure 78: France Proteomics Market Share, By Type, By Value, 2016-2026F
Figure 79: France Proteomics Market Share, By Product, By Value, 2016-2026F
Figure 80: France Proteomics Market Share, By End User, By Value, 2016-2026F
Figure 81: Italy Proteomics Market Size, By Value (USD Billion), 2016-2026F
Figure 82: Italy Proteomics Market Share, By Application, By Value, 2016-2026F
Figure 83: Italy Proteomics Market Share, By Indication, By Value, 2016-2026F
Figure 84: Italy Proteomics Market Share, By Technology, By Value, 2016-2026F
Figure 85: Italy Proteomics Market Share, By Type, By Value, 2016-2026F
Figure 86: Italy Proteomics Market Share, By Product, By Value, 2016-2026F
Figure 87: Italy Proteomics Market Share, By End User, By Value, 2016-2026F
Figure 88: Spain Proteomics Market Size, By Value (USD Billion), 2016-2026F
Figure 89: Spain Proteomics Market Share, By Application, By Value, 2016-2026F
Figure 90: Spain Proteomics Market Share, By Indication, By Value, 2016-2026F
Figure 91: Spain Proteomics Market Share, By Technology, By Value, 2016-2026F
Figure 92: Spain Proteomics Market Share, By Type, By Value, 2016-2026F
Figure 93: Spain Proteomics Market Share, By Product, By Value, 2016-2026F
Figure 94: Spain Proteomics Market Share, By End User, By Value, 2016-2026F
Figure 95: Asia-Pacific Proteomics Market Size, By Value (USD Billion), 2016-2026F
Figure 96: Asia-Pacific Proteomics Market Share, By Application, By Value, 2016-2026F
Figure 97: Asia-Pacific Proteomics Market Share, By Indication, By Value, 2016-2026F
Figure 98: Asia-Pacific Proteomics Market Share, By Technology, By Value, 2016-2026F
Figure 99: Asia-Pacific Proteomics Market Share, By Technology, By Conventional, By Value, 2016-2026F
Figure 100: Asia-Pacific Proteomics Market Share, By Technology, By Advanced, By Value, 2016-2026F
Figure 101: Asia-Pacific Proteomics Market Share, By Technology, By Quantitative, By Value, 2016-2026F
Figure 102: Asia-Pacific Proteomics Market Share, By Technology, By High-throughput, By Value, 2016-2026F
Figure 103: Asia-Pacific Proteomics Market Share, By Type, By Value, 2016-2026F
Figure 104: Asia-Pacific Proteomics Market Share, By Product, By Value, 2016-2026F
Figure 105: Asia-Pacific Proteomics Market Share, By End User, By Value, 2016-2026F
Figure 106: Asia-Pacific Proteomics Market Share, By Country, By Value, 2016-2026F
Figure 107: Japan Proteomics Market Size, By Value (USD Billion), 2016-2026F
Figure 108: Japan Proteomics Market Share, By Application, By Value, 2016-2026F
Figure 109: Japan Proteomics Market Share, By Indication, By Value, 2016-2026F
Figure 110: Japan Proteomics Market Share, By Technology, By Value, 2016-2026F
Figure 111: Japan Proteomics Market Share, By Type, By Value, 2016-2026F
Figure 112: Japan Proteomics Market Share, By Product, By Value, 2016-2026F
Figure 113: Japan Proteomics Market Share, By End User, By Value, 2016-2026F
Figure 114: China Proteomics Market Size, By Value (USD Billion), 2016-2026F
Figure 115: China Proteomics Market Share, By Application, By Value, 2016-2026F
Figure 116: China Proteomics Market Share, By Indication, By Value, 2016-2026F
Figure 117: China Proteomics Market Share, By Technology, By Value, 2016-2026F
Figure 118: China Proteomics Market Share, By Type, By Value, 2016-2026F
Figure 119: China Proteomics Market Share, By Product, By Value, 2016-2026F
Figure 120: China Proteomics Market Share, By End User, By Value, 2016-2026F
Figure 121: India Proteomics Market Size, By Value (USD Billion), 2016-2026F
Figure 122: India Proteomics Market Share, By Application, By Value, 2016-2026F
Figure 123: India Proteomics Market Share, By Indication, By Value, 2016-2026F
Figure 124: India Proteomics Market Share, By Technology, By Value, 2016-2026F
Figure 125: India Proteomics Market Share, By Type, By Value, 2016-2026F
Figure 126: India Proteomics Market Share, By Product, By Value, 2016-2026F
Figure 127: India Proteomics Market Share, By End User, By Value, 2016-2026F
Figure 128: South Korea Proteomics Market Size, By Value (USD Billion), 2016-2026F
Figure 129: South Korea Proteomics Market Share, By Application, By Value, 2016-2026F
Figure 130: South Korea Proteomics Market Share, By Indication, By Value, 2016-2026F
Figure 131: South Korea Proteomics Market Share, By Technology, By Value, 2016-2026F
Figure 132: South Korea Proteomics Market Share, By Type, By Value, 2016-2026F
Figure 133: South Korea Proteomics Market Share, By Product, By Value, 2016-2026F
Figure 134: South Korea Proteomics Market Share, By End User, By Value, 2016-2026F
Figure 135: Australia Proteomics Market Size, By Value (USD Billion), 2016-2026F
Figure 136: Australia Proteomics Market Share, By Application, By Value, 2016-2026F
Figure 137: Australia Proteomics Market Share, By Indication, By Value, 2016-2026F
Figure 138: Australia Proteomics Market Share, By Technology, By Value, 2016-2026F
Figure 139: Australia Proteomics Market Share, By Type, By Value, 2016-2026F
Figure 140: Australia Proteomics Market Share, By Product, By Value, 2016-2026F
Figure 141: Australia Proteomics Market Share, By End User, By Value, 2016-2026F
Figure 142: South America Proteomics Market Size, By Value (USD Billion), 2016-2026F
Figure 143: South America Proteomics Market Share, By Application, By Value, 2016-2026F
Figure 144: South America Proteomics Market Share, By Indication, By Value, 2016-2026F
Figure 145: South America Proteomics Market Share, By Technology, By Value, 2016-2026F
Figure 146: South America Proteomics Market Share, By Technology, By Conventional, By Value, 2016-2026F
Figure 147: South America Proteomics Market Share, By Technology, By Advanced, By Value, 2016-2026F
Figure 148: South America Proteomics Market Share, By Technology, By Quantitative, By Value, 2016-2026F
Figure 149: South America Proteomics Market Share, By Technology, By High-throughput, By Value, 2016-2026F
Figure 150: South America Proteomics Market Share, By Type, By Value, 2016-2026F
Figure 151: South America Proteomics Market Share, By Product, By Value, 2016-2026F
Figure 152: South America Proteomics Market Share, By End User, By Value, 2016-2026F
Figure 153: South America Proteomics Market Share, By Country, By Value, 2016-2026F
Figure 154: Brazil Proteomics Market Size, By Value (USD Billion), 2016-2026F
Figure 155: Brazil Proteomics Market Share, By Application, By Value, 2016-2026F
Figure 156: Brazil Proteomics Market Share, By Indication, By Value, 2016-2026F
Figure 157: Brazil Proteomics Market Share, By Technology, By Value, 2016-2026F
Figure 158: Brazil Proteomics Market Share, By Type, By Value, 2016-2026F
Figure 159: Brazil Proteomics Market Share, By Product, By Value, 2016-2026F
Figure 160: Brazil Proteomics Market Share, By End User, By Value, 2016-2026F
Figure 161: Argentina Proteomics Market Size, By Value (USD Billion), 2016-2026F
Figure 162: Argentina Proteomics Market Share, By Application, By Value, 2016-2026F
Figure 163: Argentina Proteom
